Suppliers / Bharat Parenterals

Bharat Parenterals

Nigeria 288 employees Updated 9 July 2026

Bharat Parenterals is a finished-dose manufacturer based in Nigeria. It appears in 143 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG), FDA (GH) and UZPHARM (UZ). Its GMP standing is certified by NAFDAC (NG) and FDA (GH). Customs aggregates show $9.6M of exports covering 577 molecules to 20 destinations in 2025.

0
active US DMFs
0
valid CEPs
1
registered plants
143
filings across 8 regulators

Registered plants

Site FDA FEI
GUJARAT STATE, Nigeria Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
NAFDAC (NG) 106 2
FDA (GH) 14 1
UZPHARM (UZ) 9 None
DIGEMAPS (DO) 7 None
ZAMRA (ZM) 3 None
DAV (Vietnam) 2 None

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $1.6M 9
2025 Not reported $9.6M 20
2024 Not reported $27.9M 23
2023 Not reported $15.7M 24

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Bharat Parenterals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts